$9.00
-0.15 (-1.64%)
EXACT Sciences Corp (NASDAQ:EXAS)
CAPS Rating:
An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.
An applied genomics company that develops proprietary DNA-based technologies for use in the detection of cancer.